Investment
Features
FeesSafety
Academy
More
Pluang+

Renegade Gold reports high-grade gold samples up to 56.1 g/t Au at BobJo project in Ontario.

Market News
19 Oct 2026
Newsfile Corp
View Source
Bullish
Renegade Gold reports high-grade gold samples up to 56.1 g/t Au at BobJo project in Ontario.

Renegade Gold Inc. announced new surface sampling results from its BobJo project near Red Lake, Ontario, revealing high-grade gold mineralization with channel samples up to 16.2 g/t Au over 5 meters and grab samples reaching 65.3 g/t Au. These findings confirm the presence of valuable gold veins extending over 100 meters and support the company's greenfield exploration efforts across the Confederation Belt. The company plans to integrate these results with historical data and drone surveys to prioritize targets for drilling in 2027.

Renegade Gold's new assay results offer context for readers interested in precious metals. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 19, 2026 18:11 WIB: Out of 83 priced US stocks, 44 rose and 29 fell. Notable movers include LAC at USD 2.24 (+2.75%), CRS at USD 386.12 (+2.39%), and USAR at USD 10.78 (+2.28%).

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
34 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
34 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
34 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
34 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
34 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App